PPARG and chronic obstructive pulmonary disease: This study confirms that its alkaloids mediate both COPD efficacy and hepatotoxicity, exhibiting significant overlap in chemical structures, targets (e.g., CASP3, PPARG), and signaling pathways (PI3K-Akt, VEGF, cGMP-PKG).